Trypanothione-dependent redox and thiol metabolism enzymes (TR/TryS system)

The trypanothione-dependent redox and thiol metabolism enzymes constitute a specialized antioxidant system unique to kinetoplastid parasites, such as Leishmania. This system centers around trypanothione, a dithiol consisting of two glutathione molecules linked by a spermidine bridge, which replaces the glutathione/glutathione reductase system found in humans (Fairlamb & Cerami, 1992). Key enzymes in this pathway, including trypanothione reductase (TR) and trypanothione synthetase (TryS), are essential for maintaining the parasite's internal redox environment and defending against oxidative bursts from host macrophages (Krauth-Siegel & Comini, 2008). Because these enzymes are structurally and functionally distinct from their mammalian counterparts, they are primary targets for drug discovery. Current treatments like pentavalent antimonials are believed to inhibit these enzymes, leading to a lethal accumulation of reactive oxygen species within the parasite (Wyllie et al., 2004). Targeting this pathway offers a strategy for achieving selective toxicity against Leishmania while minimizing damage to host tissues. Inhibition of these enzymes disrupts the parasite's ability to synthesize DNA and manage oxidative stress. This metabolic vulnerability is exploited by several experimental and clinical anti-leishmanial agents. The absence of this pathway in humans makes it a cornerstone of modern drug development efforts for leishmaniasis.

Other names

Trypanothione metabolismTrypanothione systemKinetoplastid thiol metabolismTrypanothione-dependent redox pathway

Inhibition of enzymes like trypanothione reductase prevents the recycling of oxidized trypanothione to its reduced form, disrupting the parasite's primary defense against oxidative stress and leading to parasite death (Fairlamb & Cerami, 1992; Krauth-Siegel & Comini, 2008).